Tradewinds Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Tradewinds Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-28	Closed	-$1K	–	766
2017 Q4	$1K	Hold	28	–	–	﹤0.01%	677
2017 Q3	$1K	Hold	28	–	–	﹤0.01%	654
2017 Q2	$1K	Hold	28	–	–	﹤0.01%	644
2017 Q1	$1K	Sell	28 -200	-88%	-$4.29K	﹤0.01%	662
2016 Q4	$4K	Sell	228 -1,079	-83%	-$26.4K	﹤0.01%	486
2016 Q3	$39K	Hold	1,307	–	–	0.03%	223
2016 Q2	$50K	Hold	1,307	–	–	0.04%	197
2016 Q1	$50K	Hold	1,307	–	–	0.03%	221
2015 Q4	$57K	Hold	1,307	–	–	0.04%	203
2015 Q3	$53K	Buy	1,307 +23	+2%	+$1.01K	0.04%	203
2015 Q2	$68K	Buy	1,284 +100	+8%	+$5.31K	0.05%	190
2015 Q1	$72K	Buy	1,184 +240	+25%	+$11.6K	0.05%	175
2014 Q4	$49K	Buy	+944	New	+$42.2K	0.04%	218

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Tradewinds Capital Management's JUNO Position: Q1 2018 in Review

Tradewinds Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 28 shares — an estimated $1K sold.

Tradewinds Capital Management first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $72K in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Tradewinds Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Tradewinds Capital Management sold 28 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1K.
Tradewinds Capital Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
Tradewinds Capital Management's Juno Therapeutics, Inc. position peaked at $72K in Q1 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Tradewinds Capital Management's 13F filing for Q1 2018, filed 2 May 2018.